Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
News-Medical.Net on MSN
Next-generation sequencing expands possibilities for newborn screening
Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before ...
New validated automated workflows enable higher-throughput, more reproducible NGS library preparation using on-deck fragmentation, ligation, and auto-normalization.
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
MedGenome unveils MetaSeq, a groundbreaking blood test capable of detecting over 1,400 pathogens in just five days, enhancing ...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...
GlobalData on MSN
Quest launches flow cytometry MRD test for myeloma
Quest expects the new blood test will support response monitoring in clinical trials.
Ongoing combination of Twist NGS library preparation kits with firefly will continue to expand SPT Labtech’s portfolio of ...
MedGenome expands its infectious disease testing portfolio with MetaSeq, a single test that detects over 1,400 pathogens: Our Bureau, Bengaluru Thursday, February 5, 2026, 14:15 H ...
The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...
Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms emerge. Newborn ...
Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results